These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 38040089)

  • 41. Advances in the Determination of Anabolic-Androgenic Steroids: From Standard Practices to Tailor-Designed Multidisciplinary Approaches.
    Huml L; Tauchen J; Rimpelová S; Holubová B; Lapčík O; Jurášek M
    Sensors (Basel); 2021 Dec; 22(1):. PubMed ID: 35009549
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Interdisciplinary and Psychiatric Treatment of Anabolic Androgenic Steroids Users.
    Butzke I; Iff S; Zitzmann M; Quednow BB; Claussen MC
    Praxis (Bern 1994); 2022 Apr; 111(6):e339-e344. PubMed ID: 35473322
    [No Abstract]   [Full Text] [Related]  

  • 43. The efficacy of ergogenic agents in athletic competition. Part I: Androgenic-anabolic steroids.
    Smith DA; Perry PJ
    Ann Pharmacother; 1992 Apr; 26(4):520-8. PubMed ID: 1533554
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Anabolic-androgenic steroids and testosterone precursors: ergogenic aids and sport.
    Foster ZJ; Housner JA
    Curr Sports Med Rep; 2004 Aug; 3(4):234-41. PubMed ID: 15231229
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Endocrine aspects of anabolic steroids.
    Wu FC
    Clin Chem; 1997 Jul; 43(7):1289-92. PubMed ID: 9216476
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Assessing the prevalence and knowledge of anabolic steroid use in male athletes in Al Madina Al Munawara, Saudi Arabia.
    Alrehaili BD; Miski SF; Alzahrani FM
    Saudi Med J; 2024 Jul; 45(7):731-740. PubMed ID: 38955450
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Detection of anabolic androgenic steroid abuse in doping control using mammalian reporter gene bioassays.
    Houtman CJ; Sterk SS; van de Heijning MP; Brouwer A; Stephany RW; van der Burg B; Sonneveld E
    Anal Chim Acta; 2009 Apr; 637(1-2):247-58. PubMed ID: 19286037
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Left ventricular early myocardial dysfunction after chronic misuse of anabolic androgenic steroids: a Doppler myocardial and strain imaging analysis.
    D'Andrea A; Caso P; Salerno G; Scarafile R; De Corato G; Mita C; Di Salvo G; Severino S; Cuomo S; Liccardo B; Esposito N; Calabrò R
    Br J Sports Med; 2007 Mar; 41(3):149-55. PubMed ID: 17178777
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Hidden Danger of Irrational Abusing Illegal Androgenic-anabolic Steroids in Recreational Athletes Age Under 35 in Bosnia & Herzegovina.
    Solakovic S; Totic D; Vukas H; Djedovic M
    Med Arch; 2015 Jun; 69(3):200-2. PubMed ID: 26261392
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Is there a potential immune dysfunction with anabolic androgenic steroid use?: A review.
    Brenu EW; McNaughton L; Marshall-Gradisnik SM
    Mini Rev Med Chem; 2011 May; 11(5):438-45. PubMed ID: 21443507
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Baseline characteristics of the HAARLEM study: 100 male amateur athletes using anabolic androgenic steroids.
    Smit DL; de Hon O; Venhuis BJ; den Heijer M; de Ronde W
    Scand J Med Sci Sports; 2020 Mar; 30(3):531-539. PubMed ID: 31663164
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Impaired cardiac structure and systolic function in athletes using supra-physiological doses of anabolic androgenic steroids.
    Hammoud S; van den Bemt BJF; Jaber A; Kurdi M
    J Sci Med Sport; 2023 Oct; 26(10):514-521. PubMed ID: 37758530
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The Central Effects of Androgenic-anabolic Steroid Use.
    Mędraś M; Brona A; Jóźków P
    J Addict Med; 2018; 12(3):184-192. PubMed ID: 29470183
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Abuse of anabolic androgenic steroids and related substances in sport and exercise.
    Bahrke MS; Yesalis CE
    Curr Opin Pharmacol; 2004 Dec; 4(6):614-20. PubMed ID: 15525553
    [TBL] [Abstract][Full Text] [Related]  

  • 55. MECHANISMS IN ENDOCRINOLOGY: Medical consequences of doping with anabolic androgenic steroids: effects on reproductive functions.
    Nieschlag E; Vorona E
    Eur J Endocrinol; 2015 Aug; 173(2):R47-58. PubMed ID: 25805894
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Use of steroids for self-enhancement: an epidemiologic/societal perspective.
    Yesalis CE
    AIDS Read; 2001 Mar; 11(3):157-60. PubMed ID: 17004353
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Anabolic Androgenic Steroid (AAS) related deaths: autoptic, histopathological and toxicological findings.
    Frati P; Busardò FP; Cipolloni L; Dominicis ED; Fineschi V
    Curr Neuropharmacol; 2015 Jan; 13(1):146-59. PubMed ID: 26074749
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Acute myocardial infarction in a young bodybuilder taking anabolic androgenic steroids: A case report and critical review of the literature.
    Christou GA; Christou KA; Nikas DN; Goudevenos JA
    Eur J Prev Cardiol; 2016 Nov; 23(16):1785-1796. PubMed ID: 27184497
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Doping in sport: effects, harm and misconceptions.
    Birzniece V
    Intern Med J; 2015 Mar; 45(3):239-48. PubMed ID: 25369881
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Current perspectives on anabolic-androgenic steroid abuse.
    Lukas SE
    Trends Pharmacol Sci; 1993 Feb; 14(2):61-8. PubMed ID: 8480376
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.